Hydroxypinacolone 9-cis Retinoate Mitigates UV-Induced Photoaging by Modulating ECM, Fibroblasts, Inflammation, and Melanogenesis.

Summary

Using multi-omics in a UV-induced photoaging model and a single-blind split-face trial (n=31), 0.03% 9-cis HPR restored ECM, rebalanced dermal cell populations, and suppressed melanogenesis with no observed irritation, matching or outperforming 0.3% retinol over 4 weeks. Mechanistically, it upregulated collagen/elastin genes, limited myofibroblast differentiation, and modulated fibroblast–melanocyte signaling.

Key Findings

• In UVR-exposed mice, 9-cis HPR reduced erythema/desquamation and increased collagen and elastin deposition.
• Single-cell and spatial transcriptomics showed restored fibroblast/basal cell/melanocyte proportions, suppressed myofibroblast differentiation, and upregulated ECM genes (Col1a2, Col3a1, Elastin).
• 9-cis HPR downregulated melanogenesis (Tyr, Dct, Tyrp1), melanosome genes (Mlana, Pmel), and Kit, likely via ROS suppression.
• In a single-blind, split-face trial (n=31), 0.03% 9-cis HPR matched or exceeded 0.3% retinol for wrinkles, elasticity, hydration, dermal density, and radiance with no observed irritation over 4 weeks.

Clinical Implications

9-cis HPR may offer a lower-irritation alternative to retinol for photoaging, enabling daily use at lower concentrations with benefits in wrinkles, elasticity, hydration, and pigmentation control.

Limitations

• Short 4-week clinical duration and small sample size in a single population (Chinese women)
• Single-blind design; long-term safety and efficacy data are lacking

Future Directions

Conduct longer, multicenter randomized trials across diverse populations, dose-ranging studies, and human tissue mechanistic validation to confirm durability and safety.